期刊文献+

早期或晚期使用枸橼酸咖啡因防治极低出生体重儿呼吸暂停的临床分析 被引量:17

Clinical effect of early or late administration of caffeine citrate in prevention and treatment of apnea in very low birth weight infants
在线阅读 下载PDF
导出
摘要 目的比较早期或晚期使用枸橼酸咖啡因防治极低出生体重儿呼吸暂停的临床效果。方法选取2015年6月至2017年5月于新生儿重症监护室住院治疗的极低出生体重儿共82例为研究对象,按开始使用枸橼酸咖啡因的日龄分为早期治疗组(日龄<3d)(n=22)和晚期治疗组(3d≤日龄<10d)(n=60),回顾性收集并比较两组患儿围产期的基本情况、治疗过程情况及临床结局。结果早期治疗组的出生体重明显低于晚期治疗组(P=0.004);早期治疗组机械通气时间及吸氧时间明显短于晚期治疗组(P<0.05);早期治疗组支气管肺发育不良(BPD)的发生率明显低于晚期治疗组(P=0.032)。其余基本情况、治疗过程情况及临床结局在两组间比较差异均无统计学意义(P>0.05)。结论早期使用枸橼酸咖啡因可改善极低出生体重儿的预后。 Objective To study the clinical effect of early or late administration of caffeine citrate in the prevention and treatment of apnea in very low birth weight(VLBW) infants.Methods A total of 82 VLBW infants who were hospitalized and treated in the neonatal intensive care unit between June 2015 and May 2017 were enrolled.According to the age in days when caffeine citrate treatment was started,they were divided into early treatment group(<3 days) with 22 infants and late treatment group(3-<10 days) with 60 infants.A retrospective analysis was performed for their clinical data.The two groups were compared in terms of general information during the perinatal period,treatment process,and clinical outcome.Results Compared with the late treatment group,the early treatment group had a significantly lower birth weight(P=0.004),significantly shorter durations of mechanical ventilation and oxygen inhalation(P<0.05),and a significantly lower incidence rate of bronchopulmonary dysplasia(P=0.032).There were no significant differences in other general information,treatment process,and clinical outcome between the two groups(P>0.05).Conclusions Early administration of caffeine citrate can improve the prognosis of VLBW infants.
作者 封云 程锐 赵莉 陈许 茅晓楠 邱洁 FENG Yun;CHENG Rui;ZHAO Li;CHEN Xu;MAO Xiao-Nan;QIU Jie(Department of Neonatology,Children's Hospital of Nanjing Medical University,Nanjing 210008,China)
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2018年第12期979-984,共6页 Chinese Journal of Contemporary Pediatrics
基金 国家自然科学基金(81671500) 江苏省妇幼健康科研项目(F201644) 第十四批江苏省"六大人才高峰"高层次人才(WSN-157) "十三五"南京市卫生青年人才工程(QRX17076)
关键词 呼吸暂停 支气管肺发育不良 枸橼酸咖啡因 极低出生体重儿 Apnea Bronchopulmonary dysplasia Caffeine citrate Very low birth weight infant
  • 相关文献

参考文献4

二级参考文献32

  • 1National Institute of Health. National Institute of Health consen- sus development of infantile apnea and home monitoring [ J 1. Pe- diatrics, 1987,79(2) :292-299.
  • 2Zhao J, Gonzalez F, Mu D. Apnea of prematurity: from cause to treatment[J]. Eur J Pediatr, 2011,170:1097-1105.
  • 3Kuzemko JA, Paala J. Apnoeic attacks in the newborn treated with aminophylline [ J ]. Arch Dis Chiht, 1973,48 : 404-406.
  • 4Aranda JV, Gorman W, Bergsteinsson H, et al.Efficacy of caf- feine in treatment of apnea in the low-birth-weight infant [J]. J Pediatr, 1977,90:467-472.
  • 5Bumard ED, Moore. RG, Nichol H. A trial of doxapram in the recurrent apnea of prematurity [ M ]//Stern L, Oh W, Fris-Han- sen B. Intensive care in the newborn I. New York: Masson Press, 1978:143-148.
  • 6New drug application: CAFCIT (NDA) 020793 [Z].Washing- ton, DC : Food and Drug Administration, 2000.
  • 7Kitchen WH, Doyle LW, Ford GW, et aL Cerebral palsy in very low-birth-weight infants surviving to 2 years with modern peri- natal intensive eare [ J ]. Am J Perinatol, 1987,4 : 29-35.
  • 8Davis PG, Doyle LW, Rickards AL, et al. Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birth- weight [J ]. J Paediatr Child Health, 2000,36 ( 1 ) :47-50.
  • 9Henderson-Smart D J, Steer PA. Prophylactic methylxanthine for preventing of apnea in preterm infants [J]. Cochrane Data- base Syst Rev, 2000 (2) : CD000432.
  • 10Mueni E, Opiyo N, English M. Caffeine for the management of apnea in preterm infants [ J ]. Int Health, 2009,1 (2) : 190-195.

共引文献398

同被引文献113

引证文献17

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部